Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential...

Area of Science:

• Regenerative Medicine
• Pediatric Therapeutics
• Stem Cell Biology

Background:

• Mesenchymal stem cells (MSCs) offer potential for diverse pediatric diseases.
• Existing clinical trials demonstrate MSC efficacy but show significant variability in approaches.

Purpose of the Study:

• To review current MSC clinical trials in pediatric populations.
• To identify factors crucial for optimizing MSC therapeutic efficacy in children.
• To guide future preclinical and clinical research in pediatric regenerative medicine.

Main Methods:

• Review of published clinical trials involving MSCs for pediatric diseases.
• Analysis of MSC sources: bone marrow, umbilical cord, placenta, amniotic fluid, adipose tissue.
• Identification of key therapeutic variables influencing MSC efficacy.

Main Results:

• MSCs are efficacious across various pediatric conditions (pulmonary, cardiac, orthopedic, endocrine, neurologic, hematologic).
• Significant heterogeneity exists in administration routes, dosage, timing, and ex vivo manipulation.
• Donor, host, and immunologic factors (allogeneic therapy) require further investigation.

Conclusions:

• Optimizing MSC therapy in pediatrics necessitates examining specific factors like administration, dose, timing, and cell processing.
• Addressing these variables is essential for maximizing therapeutic benefits for each child and disease.
• Further research and standardized approaches are needed to translate MSC potential into effective clinical practice.